Cart
sales@molnova.com
Afimetoran
CAS No. 2171019-55-7
Afimetoran( BMS-986256 )
Catalog No. M28229 CAS No. 2171019-55-7
Afimetoran is a toll-like receptor antagonist, which can be used in the research of inflammatory and autoimmune diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | Get Quote |
|
| 10MG | 295 | Get Quote |
|
| 25MG | 502 | Get Quote |
|
| 50MG | 709 | Get Quote |
|
| 100MG | 1008 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAfimetoran
-
NoteResearch use only, not for human use.
-
Brief DescriptionAfimetoran is a toll-like receptor antagonist, which can be used in the research of inflammatory and autoimmune diseases.
-
DescriptionAfimetoran is a toll-like receptor antagonist, which can be used in the research of inflammatory and autoimmune diseases.
-
In Vitro——
-
In Vivo——
-
SynonymsBMS-986256
-
PathwayImmunology/Inflammation
-
TargetTLR
-
Recptormitotic kinesin Kif18A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2171019-55-7
-
Formula Weight444.57
-
Molecular FormulaC26H32N6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (224.94 mM)
-
SMILESCC(C)c1c(-c2cn3ncnc3c(C)c2C)[nH]c2c1cc(C1CCN(CC(N)=O)CC1)cc2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tamayo NA, et al. Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe. J Med Chem. 2022;65(6):4972-4990.
molnova catalog
related products
-
Loxoribine
Loxoribine is a guanosine analog. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist. It has anti-viral and anti-tumor activities.Loxoribine is a potent new immunostimulant with a relatively broad spectrum of immunobiological activities.
-
CU-CPD107
CU-CPD107 is a selective agonist of toll-like receptor 8 (TLR8) and also shows activation activity against ssRNA ligands. CU-CPD107 acts as an inhibitor of TLR8 signaling in the presence of R848 (IC50=13.7 μM).
-
CU-115
CU-115 is a selective antagonist of TLR8 with IC50s of 1.04 μM and >50 μM for TLR8 and TLR7, respectively.
